Authors: Porter, DC Zhang, N Danes, C McGahren, MJ Harwell, RM Faruki, S Keyomarsi, K

Citation: Dc. Porter et al., Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight forms, MOL CELL B, 21(18), 2001, pp. 6254-6269

Authors: Ansardi, DC Porter, DC Jackson, CA Gillespie, GY Morrow, CD

Citation: Dc. Ansardi et al., RNA replicons derived from poliovirus are directly oncolytic for human tumor cells of diverse origins, CANCER RES, 61(23), 2001, pp. 8470-8479

Authors: Harwell, RM Porter, DC Danes, C Keyomarsi, K

Citation: Rm. Harwell et al., Processing of cyclin E differs between normal and tumor breast cells, CANCER RES, 60(2), 2000, pp. 481-489

Authors: Morrow, CD Novak, MJ Ansardi, DC Porter, DC Moldoveanu, Z

Citation: Cd. Morrow et al., Recombinant viruses as vectors for mucosal immunity, CURR T MICR, 236, 1999, pp. 255-273

Authors: Rao, S Porter, DC Chen, XM Herliczek, T Lowe, M Keyomarsi, K

Citation: S. Rao et al., Lovastatin-mediated G(1) arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase, P NAS US, 96(14), 1999, pp. 7797-7802